UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects

Neuropsychopharmacology (New York, N.Y.), 2021-02, Vol.46 (3), p.537-544

2021

Volltextzugriff (PDF)

Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects

Neuropsychopharmacology (New York, N.Y.), 2020-02, Vol.45 (3), p.462-471

2020

Volltextzugriff (PDF)

Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis

Scientific reports, 2021-05, Vol.11 (1), p.10851-10851, Article 10851

2021

Volltextzugriff (PDF)

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects

Neuropsychopharmacology (New York, N.Y.), 2022-05, Vol.47 (6), p.1180-1187

2022

Volltextzugriff (PDF)

MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens

Neuropsychopharmacology (New York, N.Y.), 2021-02, Vol.46 (3), p.545-553

2021

Volltextzugriff (PDF)

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers

Journal of psychopharmacology (Oxford), 2021-04, Vol.35 (4), p.398-405

2021

Volltextzugriff (PDF)

The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies

Journal of psychopharmacology (Oxford), 2024-01, Vol.38 (1), p.80-100

2024

Volltextzugriff (PDF)

Correction to: Safety pharmacology of acute LSD administration in healthy subjects

Psychopharmacology, 2022-02, Vol.239 (2), p.661-661

2022

Volltextzugriff (PDF)

Role of the 5-HT2A Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin

Frontiers in pharmacology, 2021-07, Vol.12, p.711255-711255

2021

Volltextzugriff (PDF)

Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants

Translational psychiatry, 2023-05, Vol.13 (1), p.172-172, Article 172

2023

Volltextzugriff (PDF)

Treatment of a Complex Personality Disorder Using Repeated Doses of LSD—A Case Report on Significant Improvements in the Absence of Acute Drug Effects

Frontiers in psychiatry, 2020-10, Vol.11

2020

Volltextzugriff (PDF)

Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study

Biological psychiatry (1969), 2023-02, Vol.93 (3), p.215-223

2023

Volltextzugriff (PDF)

Safety pharmacology of acute LSD administration in healthy subjects

Psychopharmacology, 2022-06, Vol.239 (6), p.1893-1905

2022

Volltextzugriff (PDF)

LSD-assisted therapy in patients with anxiety: open-label prospective 12-month follow-up

British journal of psychiatry, 2024-07, p.1-9

2024

Volltextzugriff (PDF)

Pharmacokinetics, pharmacodynamics and urinary recovery of oral lysergic acid diethylamide administration in healthy participants

British journal of clinical pharmacology, 2024-01, Vol.90 (1), p.200-208

2024

Volltextzugriff (PDF)

Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects

Clinical pharmacology and therapeutics, 2022-04, Vol.111 (4), p.886-895

2022

Volltextzugriff (PDF)

Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects

British journal of clinical pharmacology, 2019-07, Vol.85 (7), p.1474-1483

2019

Volltextzugriff (PDF)

Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants

Psychopharmacology, 2022-06, Vol.239 (6), p.1933-1943

2022

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants

Clinical pharmacology and therapeutics, 2023-04, Vol.113 (4), p.822-831

2023

Volltextzugriff (PDF)

Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants

The international journal of neuropsychopharmacology, 2023-02, Vol.26 (2), p.97-106

2023

Volltextzugriff (PDF)

Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants

Neuropsychopharmacology (New York, N.Y.), 2023-12, Vol.48 (13), p.1840-1848

2023

Volltextzugriff (PDF)

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants

Neuropsychopharmacology (New York, N.Y.), 2023-10, Vol.48 (11), p.1659-1667

2023

Volltextzugriff (PDF)

Alcohol acutely enhances decoding of positive emotions and emotional concern for positive stimuli and facilitates the viewing of sexual images

Psychopharmacology, 2017, Vol.234 (1), p.41-51

2017

Volltextzugriff (PDF)

Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study

European neuropsychopharmacology, 2020-12, Vol.41, p.81-91

2020

Volltextzugriff (PDF)

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity

Neuropsychopharmacology (New York, N.Y.), 2023-07, Vol.48 (8), p.1175-1183

2023

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(33)
Life Sciences & Biomedicine
(31)
Lsd
(23)
Pharmacology & Pharmacy
(21)
Neurosciences
(20)
Humans
(19)
Neurosciences & Neurology
(19)
Psychiatry
(19)
Philosophy: Aesthetics
(16)
Western Philosophy
(16)
Western Philosophy: C 1600 To C 1900
(16)
Lysergic Acid Diethylamide
(12)
Lysergide
(12)
Double-Blind Method
(11)
Cross-Over Studies
(9)
Pharmacokinetics
(9)
Placebos
(9)
Blood Pressure
(8)
Healthy Volunteers
(8)
Hallucinogens - Pharmacology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects

Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects

Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects

MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers

The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies

Correction to: Safety pharmacology of acute LSD administration in healthy subjects

Role of the 5-HT2A Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin

Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants

Treatment of a Complex Personality Disorder Using Repeated Doses of LSD—A Case Report on Significant Improvements in the Absence of Acute Drug Effects

Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study

Safety pharmacology of acute LSD administration in healthy subjects

LSD-assisted therapy in patients with anxiety: open-label prospective 12-month follow-up

Pharmacokinetics, pharmacodynamics and urinary recovery of oral lysergic acid diethylamide administration in healthy participants

Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects

Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects

Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants

Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants

Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants

Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants

Alcohol acutely enhances decoding of positive emotions and emotional concern for positive stimuli and facilitates the viewing of sexual images

Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity

Suchergebnisse filtern